Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in kids and grown-ups . In Canada, its access is overseen by Health Canada. This https://sandoz-lisdexamfetamine-591060.tribunablog.com/this-medication-in-canada-a-detailed-guide-57945582